Physiological and pathological implications of cholesterol

Frontiers in Bioscience - Landmark

Volumn 19, Issue 3, 2014, Pages 416-428

  Cortes, Victor A ^a   Busso, Dolores ^a   Maiz, Alberto ^a   Arteaga, Antonio ^a   Nervi, Flavio ^a   Rigotti, Attilio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Atherosclerosis; Cholesterol; Development; Malformation; Membrane; Mevalonate pathway; Review

Indexed keywords

CHOLESTEROL;

ATHEROSCLEROSIS; BIOSYNTHESIS; FETUS DEVELOPMENT; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CHOLESTEROL; FETAL DEVELOPMENT; HUMANS;

EID: 84904307782     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4216     Document Type: Review

References (78)

1. R. E. Olson: Discovery of the Lipoproteins, Their Role in Fat Transport and Their Significance as Risk Factors. The Journal of Nutrition 128, 439S-443S (1998)
2. M. S. Brown and J. L. Goldstein: A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47. (1986)
3. Nobelprize.org. http://nobelprize.org/index.html
4. K. E. Bloch: Sterol structure and membrane function. CRC Crit Rev Biochem 14, 47-92 (1983)
5. Y. Lange, J. Ye, M. Rigney and T. L. Steck: Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res 40, 2264-70 (1999)
6. L. Liscum and N. J. Munn: Intracellular cholesterol transport. Biochim Biophys Acta 1438, 19-37 (1999)
7. Y. Lange and B. V. Ramos: Analysis of the distribution of cholesterol in the intact cell. J Biol Chem 258, 15130-4 (1983)
8. T. H. Haines: Do sterols reduce proton and sodium leaks through lipid bilayers? Prog Lipid Res 40, 299-324 (2001)
9. K. Simons and R. Ehehalt: Cholesterol, lipid rafts, and disease. J Clin Invest 110, 597-603 (2002)
10. K. Simons and D. Toomre: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1, 31-9 (2000)
11. J. A. Svoboda: Variability of metabolism and function of sterols in insects. Crit Rev Biochem Mol Biol 34, 49-57 (1999)
12. T. V. Kurzchalia and S. Ward: Why do worms need cholesterol? Nat Cell Biol 5, 684-8 (2003)
13. V. Matyash, C. Geier, A. Henske, S. Mukherjee, D. Hirsh, C. Thiele, B. Grant, F. R. Maxfield and T. V. Kurzchalia: Distribution and transport of cholesterol in Caenorhabditis elegans. Mol Biol Cell 12, 1725-36 (2001)
14. M. Merris, W. G. Wadsworth, U. Khamrai, R. Bittman, D. J. Chitwood and J. Lenard: Sterol effects and sites of sterol accumulation in Caenorhabditis elegans: developmental requirement for 4alpha-methyl sterols. J Lipid Res 44, 172-81 (2003)
15. C. M. Crowder, E. J. Westover, A. S. Kumar, R. E. Ostlund, Jr. and D. F. Covey: Enantiospecificity of cholesterol function in vivo. J Biol Chem 276, 44369-72 (2001)
16. K. Bloch: The biological synthesis of cholesterol. Science 150, 19-28 (1965)
17. J. L. Goldstein and M. S. Brown: Regulation of the mevalonate pathway. Nature 343, 425-430 (1990)
18. J. L. Goldstein and M. S. Brown: Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem 249, 5153-5162 (1974)
19. A. Klein, L. Amigo, M. J. Retamal, M. G. Morales, J. F. Miquel, A. Rigotti and S. Zanlungo: NPC2 is expressed in human and murine liver and secreted into bile: potential implications for body cholesterol homeostasis. Hepatology 43, 126-33 (2006)
20. H. J. Kwon, L. Abi-Mosleh, M. L. Wang, J. Deisenhofer, J. L. Goldstein, M. S. Brown and R. E. Infante: Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of Cholesterol. Cell 137, 1213-1224 (2009)
21. M. L. Wang, M. Motamed, R. E. Infante, L. Abi-Mosleh, H. J. Kwon, M. S. Brown and J. L. Goldstein: Identification of Surface Residues on Niemann-Pick C2 Essential for Hydrophobic Handoff of Cholesterol to NPC1 in Lysosomes. Cell Metabolism 12, 166-173 (2010)
22. A. Rigotti, H. E. Miettinen and M. Krieger: The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 24, 357-87 (2003)
23. A. Leiva, H. Verdejo, M. L. Benitez, A. Martinez, D. Busso and A. Rigotti: Mechanisms regulating hepatic SRBI expression and their impact on HDL metabolism. Atherosclerosis 217, 299-307 (2011)
24. G. A. Francis, R. H. Knopp and J. F. Oram: Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest 96, 78-87 (1995)
25. N. Wang, D. Lan, W. Chen, F. Matsuura and A. R. Tall: ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 101, 9774-9 (2004)
26. L. Yu, R. E. Hammer, J. Li-Hawkins, K. Von Bergmann, D. Lutjohann, J. C. Cohen and H. H. Hobbs: Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 99, 16237-42 (2002)
27. K. E. Berge, H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes and H. H. Hobbs: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290, 1771-5 (2000)
28. L. Puglielli, L. Amigo, M. Arrese, L. Nunez, A. Rigotti, J. Garrido, S. Gonzalez, G. Mingrone, A. V. Greco, L. Accatino and et al.: Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. Gastroenterology 107, 244-54 (1994)
29. I. Tabas: Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110, 905-11 (2002)
30. J. D. Horton, J. L. Goldstein and M. S. Brown: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109, 1125-31 (2002)
31. M. S. Brown and J. L. Goldstein: The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340 (1997)
32. L. J. Engelking, H. Kuriyama, R. E. Hammer, J. D. Horton, M. S. Brown, J. L. Goldstein and G. Liang: Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest 113, 1168-75 (2004)
33. L. J. Engelking, G. Liang, R. E. Hammer, K. Takaishi, H. Kuriyama, B. M. Evers, W. P. Li, J. D. Horton, J. L. Goldstein and M. S. Brown: Schoenheimer effect explained - feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J Clin Invest 115, 2489-98 (2005)
34. J. L. Goldstein, R. A. DeBose-Boyd and M. S. Brown: Protein sensors for membrane sterols. Cell 124, 35-46 (2006)
35. V. Cortes, N. Quezada, A. Rigotti and A. Maiz: [New heterodimeric nuclear receptors: key metabolic regulators with relevance in the pathophysiology and therapy of dyslipidemias and diabetes mellitus.]. Rev Med Chil 133, 1483-92 (2005)
36. F. D. Porter: Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr 15, 607-13 (2003)
37. T. E. Willnow, A. Hammes and S. Eaton: Lipoproteins and their receptors in embryonic development: more than cholesterol clearance. Development 134, 3239-49 (2007)
38. J. Steinhauer and J. E. Treisman: Lipid-modified morphogens: functions of fats. Curr Opin Genet Dev 19, 308-14 (2009)
39. L. Yao, K. Jenkins, P. S. Horn, M. H. Lichtenberg and L. A. Woollett: Inability to fully suppress sterol synthesis rates with exogenous sterol in embryonic and extraembyronic fetal tissues. Biochim Biophys Acta 1771, 1372-9 (2007)
40. K. E. Schmid and L. A. Woollett: Differential effects of polyunsaturated fatty acids on sterol synthesis rates in adult and fetal tissues of the hamster: consequence of altered sterol balance. Am J Physiol Gastrointest Liver Physiol 285, G796-803 (2003)
41. C. Roux and M. Aubry: [Teratogenic action in the rat of an inhibitor of cholesterol synthesis, AY 9944]. C R Seances Soc Biol Fil 160, 1353-7 (1966)
42. P. Yi, Z. Han, X. Li and E. N. Olson: The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Ggamma1. Science 313, 1301-3 (2006)
43. R. J. Edison and M. Muenke: Gestational exposure to lovastatin followed by cardiac malformation misclassified as holoprosencephaly. N Engl J Med 352, 2759 (2005)
44. L. J. Engelking, B. M. Evers, J. A. Richardson, J. L. Goldstein, M. S. Brown and G. Liang: Severe facial clefting in Insig-deficient mouse embryos caused by sterol accumulation and reversed by lovastatin. J Clin Invest 116, 2356-65 (2006)
45. L. M. Linck, S. J. Hayflick, D. S. Lin, K. P. Battaile, S. Ginat, T. Burlingame, K. M. Gibson, M. Honda, A. Honda, G. Salen, G. S. Tint, W. E. Connor and R. D. Steiner: Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7-dehydrocholesterol Delta(7)-reductase activity in chorionic villi. Prenat Diagn 20, 238-40 (2000)
46. G. S. Tint, H. Yu, Q. Shang, G. Xu and S. B. Patel: The use of the Dhcr7 knockout mouse to accurately determine the origin of fetal sterols. J Lipid Res 47, 1535-41 (2006)
47. K. T. Burke, P. L. Colvin, L. Myatt, G. A. Graf, F. Schroeder and L. A. Woollett: Transport of maternal cholesterol to the fetus is affected by maternal plasma cholesterol concentrations in the golden Syrian hamster. J Lipid Res 50, 1146-55 (2009)
48. J. A. McConihay, A. M. Honkomp, N. A. Granholm and L. A. Woollett: Maternal high density lipoproteins affect fetal mass and extra-embryonic fetal tissue sterol metabolism in the mouse. J Lipid Res 41, 424-32 (2000)
49. S. Yoshida and Y. Wada: Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J Lipid Res 46, 2168-74 (2005)
50. R. J. Edison, K. Berg, A. Remaley, R. Kelley, C. Rotimi, R. E. Stevenson and M. Muenke: Adverse birth outcome among mothers with low serum cholesterol. Pediatrics 120, 723-33 (2007)
51. W. Palinski, T. Yamashita, S. Freigang and C. Napoli: Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Rev 65, S182-7 (2007)
52. T. E. Willnow, J. Hilpert, S. A. Armstrong, A. Rohlmann, R. E. Hammer, D. K. Burns and J. Herz: Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci U S A 93, 8460-4 (1996)
53. R. V. Farese, Jr., S. L. Ruland, L. M. Flynn, R. P. Stokowski and S. G. Young: Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc Natl Acad Sci U S A 92, 1774-8 (1995)
54. J. Rossant and J. C. Cross: Placental development: lessons from mouse mutants. Nat Rev Genet 2, 538-48 (2001)
55. J. Stefulj, U. Panzenboeck, T. Becker, B. Hirschmugl, C. Schweinzer, I. Lang, G. Marsche, A. Sadjak, U. Lang, G. Desoye and C. Wadsack: Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1. Circ Res 104, 600-8 (2009)
56. L. A. Woollett: Review: Transport of maternal cholesterol to the fetal circulation. Placenta 32 Suppl 2, S218-21 (2011)
57. M. L. Lindegaard, C. A. Wassif, B. Vaisman, M. Amar, E. V. Wasmuth, R. Shamburek, L. B. Nielsen, A. T. Remaley and F. D. Porter: Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome. Hum Mol Genet 17, 3806-13 (2008)
58. D. Steinberg: Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part I. J Lipid Res 45, 1583-1593 (2004)
59. R. Ross: Atherosclerosis - an inflammatory disease. N Engl J Med 340, 115-26 (1999)
60. A. J. Lusis: Atherosclerosis. Nature 407, 233-41 (2000)
61. G. Kellner-Weibel, W. G. Jerome, D. M. Small, G. J. Warner, J. K. Stoltenborg, M. A. Kearney, M. H. Corjay, M. C. Phillips and G. H. Rothblat: Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler Thromb Vasc Biol 18, 423-31 (1998)
62. Y. R. Su, D. E. Dove, A. S. Major, A. H. Hasty, B. Boone, M. F. Linton and S. Fazio: Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 111, 2373-81 (2005)
63. J. C. Tardif, J. Gregoire, P. L. L'Allier, T. J. Anderson, O. Bertrand, F. Reeves, L. M. Title, F. Alfonso, E. Schampaert, A. Hassan, R. McLain, M. L. Pressler, R. Ibrahim, J. Lesperance, J. Blue, T. Heinonen and J. Rodes-Cabau: Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110, 3372-7 (2004)
64. S. E. Nissen, E. M. Tuzcu, H. B. Brewer, I. Sipahi, S. J. Nicholls, P. Ganz, P. Schoenhagen, D. D. Waters, C. J. Pepine, T. D. Crowe, M. H. Davidson, J. E. Deanfield, L. M. Wisniewski, J. J. Hanyok and L. M. Kassalow: Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354, 1253-63 (2006)
65. B. Feng, D. Zhang, G. Kuriakose, C. M. Devlin, M. Kockx and I. Tabas: Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci U S A 100, 10423-8 (2003)
66. B. Feng, P. M. Yao, Y. Li, C. M. Devlin, D. Zhang, H. P. Harding, M. Sweeney, J. X. Rong, G. Kuriakose, E. A. Fisher, A. R. Marks, D. Ron and I. Tabas: The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5, 781-92 (2003)
67. I. Tabas: The Role of Endoplasmic Reticulum Stress in the Progression of Atherosclerosis. Circ Res, 107(7), 839-850 (2010)
68. A. Wechsler, A. Brafman, M. Shafir, M. Heverin, H. Gottlieb, G. Damari, S. Gozlan-Kelner, I. Spivak, O. Moshkin, E. Fridman, Y. Becker, R. Skaliter, P. Einat, A. Faerman, I. Bjorkhem and E. Feinstein: Generation of viable cholesterol-free mice. Science 302, 2087 (2003)
69. H. C. Andersson, L. Kratz and R. Kelley: Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. Am J Med Genet 113, 315-9 (2002)
70. H. R. Waterham, J. Koster, G. J. Romeijn, R. C. Hennekam, P. Vreken, H. C. Andersson, D. R. FitzPatrick, R. I. Kelley and R. J. Wanders: Mutations in the 3betahydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69, 685-94 (2001)
71. D. Huster, H. A. Scheidt, K. Arnold, A. Herrmann and P. Muller: Desmosterol may replace cholesterol in lipid membranes. Biophys J 88, 1838-44 (2005)
72. S. Rodriguez-Acebes, P. de la Cueva, C. Fernandez-Hernando, A. J. Ferruelo, M. A. Lasuncion, R. B. Rawson, J. Martinez-Botas and D. Gomez-Coronado: Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase- deficient cell line. Biochem J 420, 305-15 (2009)
73. S. C. Smith, E. J. Benjamin, R. O. Bonow, L. T. Braun, M. A. Creager, B. A. Franklin, R. J. Gibbons, S. M. Grundy, L. F. Hiratzka, D. W. Jones, D. M. Lloyd-Jones, M. Minissian, L. Mosca, E. D. Peterson, R. L. Sacco, J. Spertus, J. H. Stein and K. A. Taubert: AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update. Circulation 124, 2458-2473 (2011)
74. J. D. Horton, J. C. Cohen and H. H. Hobbs: PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50 Suppl, S172-7 (2009)
75. J. C. Cohen, E. Boerwinkle, T. H. Mosley, Jr. and H. H. Hobbs: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354, 1264-72 (2006)
76. M. A. Mishkel: Neonatal plasma lipids as measured in cord blood. Can Med Assoc J 111, 775-80 (1974)
77. D. Steinberg, J. Avigan and E. B. Feigelson: Effects of Triparanol (Mer-29) on Cholesterol Biosynthesis and on Blood Sterol Levels in Man. J Clin Invest 40, 884-93 (1961)
78. W. Modell: Mass drug catastrophes and the roles of science and technology. Science 156, 346-51 (1967)